| ZONGERTINIB 
| ZONGERTINIB | ANTINEOPLASTIC EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) KINASE INHIBITOR TREATMENT OF NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) | ORAL | Cmax 3 MICROMOLAR Tmax 2 HOUR F 76 PERCENT VD 118 LITER PPB 99 PERCENT Cl 6.9 LITER / HOUR HT 12 HOUR SOLUBILITY PRACTICALLY INSOLUBLE AT PH 6.8 | EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |